secwatch.observer — SEC 8-K summary
======================================

Issuer:     Onconetix, Inc. (ONCO)
CIK:        0001782107
Form:       8-K
Filed at:   2026-02-09T23:59:59+00:00
Accession:  0001213900-26-013724
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Onconetix shareholders approve reverse stock split (1:2 to 1:50) at special meeting
--------------------------------------------------------------------------------

- Reverse stock split proposal passed with 562,803 votes for, 123,144 against, 986 abstentions.
- Board authorized to implement split at any ratio between 1-for-2 and 1-for-50 on or before Feb 3, 2027.
- Adjournment proposal also approved with 567,357 votes for, 118,604 against, 972 abstentions.
- Total outstanding shares as of Dec 12, 2025 record date: 1,555,015 shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782107/000121390026013724/0001213900-26-013724-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782107/000121390026013724/ea0276183-8k_onconetix.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-013724

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer